Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer. (2018)

First Author: Chou A

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2017-315144

PubMed Identifier: 29080858

Publication URI: http://europepmc.org/abstract/MED/29080858

Type: Journal Article/Review

Volume: 67

Parent Publication: Gut

Issue: 12

ISSN: 0017-5749